Michal Stark

1.4k total citations
31 papers, 1.1k citations indexed

About

Michal Stark is a scholar working on Molecular Biology, Rheumatology and Oncology. According to data from OpenAlex, Michal Stark has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 10 papers in Rheumatology and 7 papers in Oncology. Recurrent topics in Michal Stark's work include Folate and B Vitamins Research (9 papers), Drug Transport and Resistance Mechanisms (6 papers) and Acute Myeloid Leukemia Research (4 papers). Michal Stark is often cited by papers focused on Folate and B Vitamins Research (9 papers), Drug Transport and Resistance Mechanisms (6 papers) and Acute Myeloid Leukemia Research (4 papers). Michal Stark collaborates with scholars based in Israel, Netherlands and United States. Michal Stark's co-authors include Yehuda G. Assaraf, Shachar Raz, Eran Bram, Lilah Rothem, Gerrit Jansen, Bluma Berman, Benny Zhitomirsky, Nitzan Gonen, Irit Avivi and Ariel Kaplan and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Michal Stark

31 papers receiving 1.1k citations

Peers

Michal Stark
Roberta E. Burden United Kingdom
Scott Cooper United States
Marilynn Vetzel United States
Maureen H. Beresini United States
Marc Abrams United States
Robert J. Slack United Kingdom
Joyce K. Randolph United States
Roberta E. Burden United Kingdom
Michal Stark
Citations per year, relative to Michal Stark Michal Stark (= 1×) peers Roberta E. Burden

Countries citing papers authored by Michal Stark

Since Specialization
Citations

This map shows the geographic impact of Michal Stark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michal Stark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michal Stark more than expected).

Fields of papers citing papers by Michal Stark

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michal Stark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michal Stark. The network helps show where Michal Stark may publish in the future.

Co-authorship network of co-authors of Michal Stark

This figure shows the co-authorship network connecting the top 25 collaborators of Michal Stark. A scholar is included among the top collaborators of Michal Stark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michal Stark. Michal Stark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Stark, Michal, Shachar Raz, & Yehuda G. Assaraf. (2021). Folylpoly-ɣ-glutamate synthetase association to the cytoskeleton: Implications to folate metabolon compartmentalization. Journal of Proteomics. 239. 104169–104169. 7 indexed citations
3.
Stark, Michal, et al.. (2021). Deciphering molecular mechanisms underlying chemoresistance in relapsed AML patients: towards precision medicine overcoming drug resistance. Cancer Cell International. 21(1). 53–53. 28 indexed citations
4.
6.
Zhitomirsky, Benny, et al.. (2018). Lysosomotropic drugs activate TFEB via lysosomal membrane fluidization and consequent inhibition of mTORC1 activity. Cell Death and Disease. 9(12). 1191–1191. 93 indexed citations
7.
Giovannetti, Elisa, Paolo Andrea Zucali, Yehuda G. Assaraf, et al.. (2017). Role of proton-coupled folate transporter in pemetrexed resistance of mesothelioma: clinical evidence and new pharmacological tools. Annals of Oncology. 28(11). 2725–2732. 37 indexed citations
8.
Stark, Michal & Yehuda G. Assaraf. (2017). Structural recognition of tubulysin B derivatives by multidrug resistance efflux transporters in human cancer cells. Oncotarget. 8(30). 49973–49987. 6 indexed citations
9.
Raz, Shachar, Michal Stark, & Yehuda G. Assaraf. (2016). Folylpoly-γ-glutamate synthetase: A key determinant of folate homeostasis and antifolate resistance in cancer. Drug Resistance Updates. 28. 43–64. 64 indexed citations
10.
Yeheskely‐Hayon, Daniella, et al.. (2013). The Roles of the Catalytic and Noncatalytic Activities of Rpd3L and Rpd3S in the Regulation of Gene Transcription in Yeast. PLoS ONE. 8(12). e85088–e85088. 10 indexed citations
11.
12.
Stark, Michal, Eran Bram, Patrycja Nowak‐Sliwinska, et al.. (2012). Imidazoacridinone-dependent lysosomal photodestruction: a pharmacological Trojan horse approach to eradicate multidrug-resistant cancers. Cell Death and Disease. 3(4). e293–e293. 83 indexed citations
13.
Stark, Michal, et al.. (2010). Heterogeneous Nuclear Ribonucleoprotein H1/H2-dependent Unsplicing of Thymidine Phosphorylase Results in Anticancer Drug Resistance. Journal of Biological Chemistry. 286(5). 3741–3754. 42 indexed citations
14.
Bram, Eran, Michal Stark, Shachar Raz, & Yehuda G. Assaraf. (2009). Chemotherapeutic Drug-Induced ABCG2 Promoter Demethylation as a Novel Mechanism of Acquired Multidrug Resistance. Neoplasia. 11(12). 1359–IN11. 97 indexed citations
15.
Rothem, Lilah, Bluma Berman, Michal Stark, Gerrit Jansen, & Yehuda G. Assaraf. (2005). The Reduced Folate Carrier Gene Is a Novel Selectable Marker for Recombinant Protein Overexpression. Molecular Pharmacology. 68(3). 616–624. 10 indexed citations
16.
Rothem, Lilah, Michal Stark, & Yehuda G. Assaraf. (2004). Impaired CREB-1 Phosphorylation in Antifolate-Resistant Cell Lines with Down-Regulation of the Reduced Folate Carrier Gene. Molecular Pharmacology. 66(6). 1536–1543. 17 indexed citations
17.
Assaraf, Yehuda G., et al.. (2004). Targeting an extracellular epitope of the human multidrug resistance protein 1 (MRP1) in malignant cells with a novel recombinant single chain Fv antibody. International Journal of Cancer. 110(6). 882–890. 11 indexed citations
18.
Assaraf, Yehuda G., Lilah Rothem, Jan Hendrik Hooijberg, et al.. (2003). Loss of Multidrug Resistance Protein 1 Expression and Folate Efflux Activity Results in a Highly Concentrative Folate Transport in Human Leukemia Cells. Journal of Biological Chemistry. 278(9). 6680–6686. 67 indexed citations
19.
Stark, Michal, Lilah Rothem, Gerrit Jansen, et al.. (2003). Antifolate Resistance Associated with Loss of MRP1 Expression and Function in Chinese Hamster Ovary Cells with Markedly Impaired Export of Folate and Cholate. Molecular Pharmacology. 64(2). 220–227. 35 indexed citations
20.
Rothem, Lilah, Michal Stark, Yotam Kaufman, Lior Mayo, & Yehuda G. Assaraf. (2003). Reduced Folate Carrier Gene Silencing in Multiple Antifolate-resistant Tumor Cell Lines Is Due to a Simultaneous Loss of Function of Multiple Transcription Factors but Not Promoter Methylation. Journal of Biological Chemistry. 279(1). 374–384. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026